SRP-9004
9004-101
Phase 2 gene_therapy completed
Quick answer
SRP-9004 for Limb-Girdle Muscular Dystrophy, Type 2D is a Phase 2 program (gene_therapy) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Limb-Girdle Muscular Dystrophy, Type 2D
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- completed